Skip to main content
BrainCited

描述

Preclinical evidence for antioxidant-based interventions in Alzheimer's disease models is summarized, comparing efficacy across different compound classes.

Figure 3

Source Paper

Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements.

International journal of molecular sciences (2020)

PMID: 32183152

DOI: 10.3390/ijms21061974

Cite This Figure

![Figure 3: Preclinical evidence for antioxidant-based interventions in Alzheimer's disease models is summarized, comparing efficacy across different compound classes.]()

> Source: Koh Tadokoro et al. "Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Su." *International journal of molecular sciences*, 2020. PMID: [32183152](https://pubmed.ncbi.nlm.nih.gov/32183152/)
<figure>
  <img src="" alt="Preclinical evidence for antioxidant-based interventions in Alzheimer's disease models is summarized, comparing efficacy across different compound classes." />
  <figcaption>Figure 3. Preclinical evidence for antioxidant-based interventions in Alzheimer's disease models is summarized, comparing efficacy across different compound classes.<br>  Source: Koh Tadokoro et al. "Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Su." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32183152/">32183152</a></figcaption>
</figure>